283 related articles for article (PubMed ID: 9836122)
1. [Clinical evaluation of cefozopran for infections associated with hematological malignancies].
Sasai Y; Iwai T; Tamura A; Nakazawa N; Ueda Y; Kaneko H; Horiike S; Yokota S; Taniwaki M; Kashima K; Misawa S; Tsuda S; Ohgawara Y
Jpn J Antibiot; 1998 Aug; 51(8):501-8. PubMed ID: 9836122
[TBL] [Abstract][Full Text] [Related]
2. [Efficacy and safety of cefozopran (CZOP) monotherapy and combination therapy with CZOP and amikacin (AMK) for infections accompanying hematological diseases].
Urabe A; Fujita A; Aoki K; Koike M; Kitamura K; Ohbayashi Y; Oshimi K; Wakabayashi Y; Kuraishi Y; Kurihara I; Togawa A; Hoshino S; Ozawa K; Hotta T; Higashihara M; Nagoshi H; Hirai H; Omine M; Asano S; Nishimura M; Suzuki K; Bessho M; Mizoguchi H; Furusawa S; Nonaka Y; Takaku F
Jpn J Antibiot; 2000 Feb; 53(2):61-74. PubMed ID: 10786314
[TBL] [Abstract][Full Text] [Related]
3. [Clinical evaluation of panipenem/betamipron as a second line chemotherapy in severe infections associated with hematological disorders].
Nakazawa N; Okamoto T; Kobayashi M; Iwai T; Sasai Y; Tamura A; Horiike S; Yokota S; Taniwaki M; Kashima K; Misawa S; Tuda S; Ohkawara Y
Jpn J Antibiot; 1998 Aug; 51(8):509-20. PubMed ID: 9836123
[TBL] [Abstract][Full Text] [Related]
4. [Clinical effects of combination therapy with cefozopran and tobramycin for severe infections in patients with hematologic diseases].
Toyama K; Yaguchi M; Uchida Y; Suzuki K; Sawanobori M; Ikeda Y; Matsuoka S; Wakasugi K; Furuya T; Oshimi K; Kawamata N; Kikuchi M; Murakami H; Tsuruoka N; Tomoyasu S; Kawaguchi M; Hirosawa S; Yamamoto K; Shirota T; Harada Y; Dan K; Yamada T; Kawano K; Onozawa Y; Takeuchi J
Jpn J Antibiot; 1999 Feb; 52(2):153-61. PubMed ID: 10221180
[TBL] [Abstract][Full Text] [Related]
5. [Optimum dose study of cefozopran in the pediatric field].
Fujii R; Sunakawa K; Sato Y; Yokota T; Yoshimura K; Kondoh Y; Kawaoi Y; Terashima I; Meguro H; Niinou K; Toyonaga Y; Ishihara T; Iwai N; Nakamura H; Kuno K; Miyajima Y; Sakurai M; Itoh M; Kawasaki H; Suga S; Kamiya H; Fujiwara T; Inui T; Taniguchi K; Nakayama M
Jpn J Antibiot; 1996 Jul; 49(7):663-77. PubMed ID: 8828069
[TBL] [Abstract][Full Text] [Related]
6. [Clinical evaluation of cefozopran as treatment for febrile neutropenia].
Saito T; Hara M; Shinagawa K; Nawa Y; Nakase K; Takeuchi M; Miyata A; Fukuda S; Sunami K; Imajoh K; Yano T; Kojima K; Teshima T; Fujii N; Ishimaru F; Ikeda K; Harada M; Tanimoto M
Gan To Kagaku Ryoho; 2004 Jan; 31(1):61-5. PubMed ID: 14750323
[TBL] [Abstract][Full Text] [Related]
7. [Clinical effects of combination therapy with cefozopran and amikacin for infections in patients with hematological disorders].
Fukuda M; Endo K; Takinami S; Kawai N; Tominaga K; Maesaki S; Bessho M; Yamazaki T
Jpn J Antibiot; 2001 Feb; 54(2):88-94. PubMed ID: 11338682
[TBL] [Abstract][Full Text] [Related]
8. [Pharmacokinetic and clinical studies with cefozopran in the pediatric field. Pediatric Study Group of Cefozopran].
Fujii R; Abe T; Tajima T; Terashima I; Meguro H; Nakazawa S; Sato H; Niinou K; Sunakawa K; Yokota T
Jpn J Antibiot; 1994 Jan; 47(1):102-23. PubMed ID: 8114268
[TBL] [Abstract][Full Text] [Related]
9. [Clinical evaluation of ceftazidime monotherapy for infections complicated with hematological disorders].
Kuzuyama Y; Tsuda S; Seriu T; Nakai H; Murakami T; Takashima T; Takahashi Y; Tanaka S; Nakagawa H; Nishigaki H
Jpn J Antibiot; 1992 May; 45(5):523-9. PubMed ID: 1512938
[TBL] [Abstract][Full Text] [Related]
10. [Therapeutic effects of a combination treatment with cefmetazole and netilmicin against infections complicated with hematological disorders].
Yamane T; Nakao Y; Yasui Y; Ota K; Ohira H; Inoue T; Furukawa Y; Hiyoshi M; Sasaki A; Kishida T
Jpn J Antibiot; 1990 Nov; 43(11):1843-9. PubMed ID: 2287053
[TBL] [Abstract][Full Text] [Related]
11. [Clinical investigation of the therapeutic effects of cefmenoxime in the treatment of infections complicated by hematological diseases].
Kozuru M; Kurata T; Uike N; Niho Y; Shibuya T; Otsuka T; Yamano Y; Hirota Y; Nishimura J; Katsuno M
Jpn J Antibiot; 1986 Mar; 39(3):701-12. PubMed ID: 3488422
[TBL] [Abstract][Full Text] [Related]
12. [Treatment of severe infections in hematologic malignancies with piperacillin sodium].
Kubota Y; Ohnishi H; Murata M; Nagai M; Ikeda K; Tanaka T; Irino S
Jpn J Antibiot; 1991 Mar; 44(3):317-23. PubMed ID: 1880913
[TBL] [Abstract][Full Text] [Related]
13. [Clinical evaluation of a combination therapy using cefmenoxime and cefsulodin on infections complicated by hematological disorders. Tohkai Research Group on Infections in Hematopoietic Disorders].
Minami N; Uno N; Shirakawa S; Ohno R; Okumura M; Yamamoto M; Mitomo Y; Hirano M; Shimizu S; Yamada K
Jpn J Antibiot; 1986 Mar; 39(3):713-20. PubMed ID: 3488423
[TBL] [Abstract][Full Text] [Related]
14. [Clinical evaluation of a new parenteral cephem, cefozopran, in children].
Taniuchi S; Higashino H; Takaya J; Ishizaki Y; Kino M; Man W; Kobayashi Y
Jpn J Antibiot; 1994 Nov; 47(11):1553-8. PubMed ID: 7853685
[TBL] [Abstract][Full Text] [Related]
15. [Therapeutic effects of micronomicin against severe infections in patients with hematopoietic disorders. Hanshin Infection Study Group].
Hasegawa H; Horiuchi A; Nagai K; Kanamaru A; Masaoka T; Shibata H; Kitani T; Taniguchi N; Yasunaga K; Okamoto Y
Jpn J Antibiot; 1985 Aug; 38(8):2129-38. PubMed ID: 3908733
[TBL] [Abstract][Full Text] [Related]
16. [Clinical evaluation of sulbactam/cefoperazone for severe infections associated with hematological disorders].
Kitamura K; Takaku F; Miyazaki T; Miura ; Mizoguchi H; Saito H; Masaoka T; Kimura I; Niho Y
Jpn J Antibiot; 1991 Sep; 44(9):979-86. PubMed ID: 1960859
[TBL] [Abstract][Full Text] [Related]
17. [Effects of cefoxitin in the treatment of severe infections in patients with hematopoietic disorders].
Hasegawa H; Horiuchi A; Nagai K; Kanamaru A; Masaoka T; Shibata H; Kitani T; Tsubakio T; Kawagoe H; Shinohara Y; Nasu T
Jpn J Antibiot; 1982 May; 35(5):1212-22. PubMed ID: 6752459
[TBL] [Abstract][Full Text] [Related]
18. [A combined consecutive therapy with fosfomycin and sulbactam/cefoperazone for bacterial infections associated with hematological diseases].
Misawa S; Tsuda S; Taniwaki M; Horiike S; Ariyama Y; Hirakawa K; Ueda Y; Kaneko H; Nakao M; Kashima K
Jpn J Antibiot; 1995 Apr; 48(4):514-21. PubMed ID: 7540219
[TBL] [Abstract][Full Text] [Related]
19. [Pharmacokinetic, bacteriological and clinical studies on cefozopran in neonates and premature infants. A study of cefozopran in the perinatal co-research group].
Fujii R; Okuno A; Fujita K; Kakuya F; Maruyama S; Sakata H; Inyaku F; Abe T; Hashira S; Nakazato Y; Sugiura M; Tajima T; Nagai S; Funamoto N; Sugimori S; Nishimura S; Yoshimura K; Kondoh Y; Kawaoi Y; Terashima I; Meguro H; Takeuchi Y; Kantake M; Sunakawa K; Yagisawa M
Jpn J Antibiot; 1996 Jul; 49(7):678-702. PubMed ID: 8828070
[TBL] [Abstract][Full Text] [Related]
20. [Clinical evaluation of cefozopran in the pediatric field].
Meguro H; Fujii R; Terashima I
Jpn J Antibiot; 1994 Nov; 47(11):1464-72. PubMed ID: 7853677
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
